Does GADODIAMIDE Cause Mobility decreased? 81 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Mobility decreased have been filed in association with GADODIAMIDE (OMNISCAN). This represents 10.4% of all adverse event reports for GADODIAMIDE.
81
Reports of Mobility decreased with GADODIAMIDE
10.4%
of all GADODIAMIDE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Mobility decreased From GADODIAMIDE?
Of the 81 reports, 1 (1.2%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GADODIAMIDE. However, 81 reports have been filed with the FAERS database.
What Other Side Effects Does GADODIAMIDE Cause?
Pain (216)
Gadolinium deposition disease (199)
Arthralgia (194)
Rash (188)
Paraesthesia (183)
Fatigue (175)
Asthenia (174)
Burning sensation (172)
Injury (171)
Confusional state (169)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which GADODIAMIDE Alternatives Have Lower Mobility decreased Risk?
GADODIAMIDE vs GADOLINIUM
GADODIAMIDE vs GADOPENTETATE DIMEGLUMINE
GADODIAMIDE vs GADOPICLENOL
GADODIAMIDE vs GADOTERATE MEGLUMINE
GADODIAMIDE vs GADOTERIDOL